Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety and Efficacy of Adapalene/Benzoyl Peroxide Gel in Acne Vulgaris
NCT00446043Phase 3Completed
- Sponsor
- Galderma
- Start
- Feb 2004
- Primary completion
- May 2005
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of adapalene and benzoyl peroxide + sulfur in acne vulgaris, sponsored by Galderma. Primary endpoints: Percent Change From Baseline in Inflammatory Lesion Count at 12 months, Percent Change From Baseline in Noninflammatory Lesion Count at 12 months and 2 more. Started Feb 2004; status: completed.
02
Drugs
adapalenebenzoyl peroxide + sulfur
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00446043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00446043.